Cytokine dysregulation is central to the immunopathogenesis
To elucidate the possible role of IL-10 in HIV infection, IL-10 levels in serum and IL-10 production in PBMC from of human immunodeficiency virus (HIV) infection, both in relation to regulation of HIV replication and in the development patients with different clinical stages of HIV infection and from controls were quantified in response to 2 different MAC of immunodeficiency [1, 2] . Interleukin (IL)-10 may play an important role in this cytokine dysregulation by its ability to preparations and compared with IL-10 production after stimulation with a nonspecific mitogen. Since IL-10 is produced by a down-regulate cytokine synthesis in monocytes, macrophages, and Th1 lymphocytes [3, 4] . However, present data conflict number of cell types, including monocytes, macrophages, and various lymphocyte populations [3, 10, 12 , 13], we also asregarding the level of IL-10 production in peripheral blood mononuclear cells (PBMC) from patients with HIV infection, sessed the cellular sources of IL-10 in PBMC culture after stimulation with MAC products. Finally, the PBMC response and the contribution of IL-10 to HIV immunopathogenesis is still unclear [5 -10] . A possible overproduction of IL-10 in to modulation with IL-10 in terms of production of IL-12 p40 and tumor necrosis factor (TNF)-a was assessed in cultures HIV patients with down-regulation of Th1 responses and inhibition of various macrophage functions might contribute to the of samples from patients and controls after stimulation with different MAC preparations. increased susceptibility to infections with various intracellular microbes. Mycobacterium avium complex (MAC) is one of the most important intracellular pathogens in patients with adMaterials and Methods vanced HIV infection, and it is associated with high morbidity and mortality [11] .
Patients. Blood samples were obtained from 26 HIV-infected patients followed at our department. Patients were classified clinically according to the revised criteria from Centers for Disease Control and Prevention [14] , as shown in table 1. At the time of blood sampling, 4 patients had ongoing opportunistic infections: DNA-ribosomal RNA hybridization with a M. avium -specific netic beads (Dynal, Oslo) and anti-mouse Fab antiserum (Detacha-bead CD4/CD8; Dynal) as previously described [19] . The purity probe (AccuProbe; Gen-Probe, San Diego) and was cultured in Middlebrook 7H9 broth enriched with ADC (albumin, dextrose, of the positively selected CD4 and CD8 lymphocyte subpopulations was 90%-95% as determined by flow cytometry. catalase; Difco, Detroit) for 21 days. Preparation of mycobacterial sonicate was accomplished as described by Closs et al. [15] . The
The other aliquot (3 1 10 6 PBMC/mL in culture medium), was seeded in 24-well plates (Costar; 1 mL/well), incubated for 1 h at protein concentration of the sonicate was 0.12 mg/mL as de-37ЊC, washed three times in PBS, and incubated for 10 min on termined by Lowry's method [16] . The sonicate designated ice. Adherent monocytes were scraped off the surface with a rubber MAC-SON, was aliquoted and stored at 080ЊC.
policeman, washed, counted, and resuspended in culture medium. Purified protein derivative from M. avium (MAC-PPD) was a CD14 expression was ú80% as determined by flow cytometry. gift from Reidar Bjørlo (National Veterinary Institute, Oslo).
Cell culture. PBMC were obtained from heparinized blood by use of isopaque-ficoll (Lymphoprep; Nycomed Pharma, Oslo) gradient centrifugation within 45 min after blood sampling, as previously described [17] . PBMC were resuspended in RPMI 1640 with 2 mM L-glutamine and 25 mM HEPES buffer (RPMI; Gibco BRL, Paisley, UK) supplemented with gentamicin (40 mg/L) and 10% heat-inactivated pooled human AB / serum (culture medium) at a concentration of 2 1 10 6 cells/mL. The fraction of CD14 monocytes in the isolated PBMC was determined by immunomagnetic quantification [18] .
PBMC were stimulated with phytohemagglutinin (PHA; Murex Diagnostics, Dartford, UK; final concentration, 1:100), MAC-SON (final concentration, 1:100), or MAC-PPD (final concentration, 1:100), or they were left unstimulated. Cells were cultured (0.2 1 10 6 cells/well) in flat-bottomed 96-well microtiter plates (Costar, Cambridge, MA). In additional wells, in which cells were stimulated with MAC-SON or MAC-PPD, cultures were simultaneously treated with human recombinant IL-10 (specific activity 2.01 1 10 7 U/mg, 100 U/mL) or neutralizing monoclonal anti-human IL-10 (clone 12G8, 5 mg/mL; both reagents provided by S. Narula, Schering-Plough Research Institute, Kenilworth, NJ). Patients' cells were always cultured in the same microtiter plates as control blood donor cells.
In all preparations of culture medium, the endotoxin level was õ10 pg/mL as determined by a quantitative chromogenic limulus amebocyte lysate test (BioWhittaker, Walkersville, MD).
Cultures were harvested at 24 h because the IL-10 level in the Figure 1 . Serum levels of IL-10 in blood donor controls, asympstimulated culture supernatants reached a plateau after this point.
tomatic HIV-seropositive patients (Centers for Disease Control and Plates were centrifuged at 500 g for 10 min, and the supernatants Prevention [CDC] stage A), and AIDS patients (CDC stage C). ILwere collected, aliquoted, and stored at 080ЊC until cytokine anal-10 was measured by ELISA. Bars indicate medians. All groups were yses.
compared by Kruskal-Wallis test, and Fisher's least significant differSeparation of T lymphocyte subsets and monocytes. For studence was computed on ranks to determine differences between pair ies of cytokine production in CD4 and CD8 lymphocytes and of groups. Of 3 patients with highest IL-10 levels, * had recently monocytes, PBMC were divided into 2 aliquots. One aliquot was suffered from cryptococcal meningitis, † had ongoing M. avium infecdepleted for CD14 monocytes, and then CD4 and CD8 lymphotion, while ‡ probably had visceral leishmaniasis at time of blood sampling. Asympt Å asymptomatic. cytes were positively selected with antibody-coated immunomag-Cells (10 6 cells/mL; 0.1 mL/well) were seeded in duplicates as and 0.1% (wt/vol) saponin (Sigma; a permeabilization buffer) for 30 min at 4ЊC. follows: purified CD4 lymphocytes, 90% CD4 lymphocytes plus 10% monocytes, purified CD8 lymphocytes, 90% CD8 lymphoLast, cells were washed once in permeabilization buffer, resuspended in staining buffer, and analyzed using FACScan with Cellcytes plus 10% monocytes, or only monocytes. Addition of monocytes to the lymphocyte cultures was done to accomplish presentaQuest software (both from Becton Dickinson). Samples included staining with FITC-conjugated, isotype-matched control antibodies tion of antigens in the MAC-SON preparation. Cells were stimulated with PHA or MAC-SON and cultured for 24 h, and and phycoerythrin-conjugated anti-IL-10 (0.25 mg/sample) that had been preincubated with an excess of recombinant IL-10 (1 supernatants were then harvested and stored as described above.
Quantification of IL-10-producing cells by intracellular cytomg/sample; Schering-Plough Research Institute). List mode files were collected for 25,000 cells from each sample. Calibration and kine staining. PBMC (2 1 10 6 cells/mL) were cultured in 24-well plates (Costar; 1 mL/well) for 24 h with PHA or MAC-SON adjustment of compensation were done with FacsComp software and Calibrite fluorescence beads (both from Becton Dickinson). in the presence of 2 mM monensin (Sigma, St. Louis) in order to block intracellular transport processes causing cytokine accumulaQuantification of IL-10, TNF-a, and IL-12 p40. Serum was collected as described elsewhere [21] , and circulating IL-10 was tion in the Golgi complex [20] . The plates were incubated for 10 min on ice, and the adherent cells were scraped off the surface quantified by a high-sensitivity ELISA (R&D Systems, Minneapolis). Cytokines in supernatants were quantitated in 96-well miwith a rubber policeman. Cells were washed and resuspended in PBS with 5% mouse serum (Sigma), 5% human immunoglobulin croplates (Nunc Maxisorp, Roskilde, Denmark). For the IL-10 ELISA (reagents provided by S. Narula, Schering-Plough Research (Octagam; Octapharma, Vienna), 2% bovine serum albumin (Calbiochem, La Jolla, CA), and 0.1% sodium azide. The cells were Institute), wells were coated with monoclonal rat anti-human IL-10 (clone JES3-9D7, 1 mg/mL). The reference standard was then stained (30 min at 4ЊC) for membrane antigens by fluorescein isothiocyanate (FITC)-conjugated antibodies from Becton Dickinrecombinant IL-10 (10-625 pg/mL). Subsequent steps included polyclonal rabbit anti-human IL-10 (1:2500), alkaline phosphason (San Jose, CA): CD4, clone SK 3; CD8, clone SK 1; CD14, clone Leu-M3. The cells were washed in staining buffer (PBS tase-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch, West Grove, PA; 1:5000), and p-nitrophenyl disodium with 1% fetal bovine serum; Gibco BRL), fixed in 4% (wt/vol) paraformaldehyde (Sigma) in PBS (pH 7.4) for 20 min at 4ЊC, phosphate (Sigma; 1 mg/mL in diethanolamine buffer, pH 9.8) for color development. washed in staining buffer, and stained with phycoerythrin-conjugated anti-IL-10 (PharMingen, San Diego; 0.25 mg/sample) in For the TNF-a ELISA, wells were coated with monoclonal mouse anti-human TNF-a (PharMingen; clone MAb1; 2 mg/mL PBS with 1% heat-inactivated fetal bovine serum (Gibco BRL) tion between PHA-induced IL-10 production and the CD4 lymdium phosphate as substrate. IL-12 p40 was quantified by ELISA (R&D Systems). The limit of detection was 0.7 pg/mL for the high-sensitivity IL-10 assay, 5 pg/mL for the IL-10 assay, 15 pg/mL for the IL-12 p40 assay, and 100 pg/mL for the TNF-a assays. Intra-or interassay coefficients of variation were õ10% for all assays.
Quantification of lymphocyte subsets in peripheral blood. The numbers of CD4 and CD8 lymphocytes in peripheral blood were determined by immunomagnetic quantification [22] .
Statistical methods. Wilcoxon rank sum test was used to compare data for 2 groups of subjects. When ú2 groups were compared, the Kruskal-Wallis test was used. If a significant difference was found, Fisher's least significant difference was computed on the ranks to determine differences between each pair of groups. Responses within the same individuals were compared by the Wilcoxon signed rank test for paired data. Coefficients of correlation (R) were calculated by use of Spearman's rank test. Data are given as medians and 25th -75th percentiles if not otherwise stated. P values are two sided; P õ .05 was considered significant.
Results

IL-10 in Serum
Both asymptomatic HIV-infected patients and AIDS patients had significantly higher levels of IL-10 than did controls (figure 1). Of the 3 AIDS patients with the highest IL-10 levels, 1 probably had visceral leishmaniasis at the time of blood sampling (diagnosed 6 months later; IL-10: 20.3 pg/mL), 1 had an ongoing MAC infection (IL-10: 17.1 pg/mL), and 1 was diagnosed with cryptococcus meningitis 3 months before blood sampling and was receiving maintenance treatment (IL-10: 6.8 pg/mL).
IL-10 Production in PBMC
MAC-PPD and MAC-SON induced significantly higher levels of IL-10 in cell cultures for HIV patients than in cultures for controls: MAC-PPD induced 99 pg/mL (0 -218) for HIV patients versus 0 pg/mL (0 -0) for controls (P õ .001); MAC-SON induced 214 pg/mL (102 -386) for HIV patients versus 56 pg/mL (0 -118) for controls (P õ .001) (figure 2). MAC-PPD -stimulated IL-10 production was significantly higher in symptomatic than in asymptomatic patients (figure 2). A similar IL-12 p40 production was significantly reduced to undetectable levels in cultures for both patients and controls (figure 5B).
IL-10 production by T lymphocyte subsets and monocytes.
Addition of neutralizing anti -IL-10 had the opposite effect, MAC-SON stimulation of purified and separately cultured leading to significantly higher levels of IL-12 p40 cultures for monocytes and lymphocyte subpopulations from patients and both patients and controls (figure 5B). controls revealed that IL-10 was produced only by monocytes and not by CD4 or CD8 lymphocytes ( figure 3 ). In contrast, both CD4 lymphocytes (in the presence of 10% monocytes) and monocytes contributed to the IL-10 producDiscussion tion in response to PHA, while no IL-10 production was
In the present study, we focused on the role of IL-10 in HIV detected in the CD8 lymphocytes (in the presence of 10% infection. Patients with HIV had significantly higher levels of monocytes; figure 3 ) or in purified CD4 or CD8 lymphocyte circulating IL-10 than healthy HIV-seronegative blood donors, cultures (data not shown). Similar patterns were found in with the highest levels occurring in the AIDS group. This is cells from both patients and controls, although the monocyte in accordance with data from Ameglio et al. [23] , whereas IL-10 production in the patient cultures tended to be higher Chehimi et al. [24] did not find any differences between than that in the controls after MAC-SON stimulation and IL-10 levels in HIV patients and controls. Of interest, the 3 lower after PHA stimulation.
patients in our study with the highest serum IL-10 levels (Ç2-Quantification of IL-10 producing cells by intracellular to 6-fold higher than the median level) all had ongoing or cytokine staining. To further study the cellular sources of recent infections with intracellular pathogens. This raises the IL-10 in response to various stimuli, we examined the intrapossibility that increased serum IL-10 levels in HIV infection cellular IL-10 production in PBMC by flow cytometry. In to some extent may be due to opportunistic infections rather MAC-SON -stimulated cultures, monocytes were the major than to HIV-related immunodeficiency per se. If so, differences IL-10 -producing cells, and the percentage of monocytes in patient populations with regard to opportunistic infections producing IL-10 tended to be higher in patient cultures than may partly explain the conflicting serum IL-10 data found in in control cultures, as indicated in figure 4 . In PHA-stimuvarious studies. lated cells, substantial proportions of both monocytes and Furthermore, our data show that PBMC from patients with CD4 and CD8 lymphocytes from both patients and controls HIV infection, compared with controls, respond to MAC prepaproduced IL-10 (figure 4).
rations with markedly enhanced IL-10 production. The highest IL-10 levels were found in patients with symptomatic disease,
Effect of IL-10 Modulation on TNF-a and IL-12 p40
but IL-10 production was similar in patients with or without receptors that recognize products from various microorganisms, including mycobacteria [25 -27] . Second, lymphocyte were stimulated with MAC products in the presence of recombinant IL-10, a significant reduction in TNF-a production in activation induced by MAC preparations may affect the level of monocyte IL-10 production via the secretion of various patient (MAC-SON stimulation only) and control cultures was found ( figure 5A ). Conversely, in cultures for HIV patients other cytokines [28 -31] . Third, IL-10 may be induced in vivo by other monocyte-derived factors that are elevated in stimulated by MAC products and treated with neutralizing anti -IL-10, TNF-a production was significantly increased up HIV infection, such as TNF-a and prostaglandin E 2 [32, 33] .
Others have shown that in vivo and in vitro, HIV-infected to levels found in cultures for the controls ( figure 5A ). Also, TNF-a production in control cultures was increased after neumonocytes are important contributors to IL-10 production, spontaneously and after stimulation with HIV or gp120 [10, tralization with anti -IL-10, as shown in figure 5A .
IL-12 p40. After stimulation with MAC products, no sig-13, 24, 34 -36] . Also, products from Mycobacterium tuberculosis [37] and Mycobacterium leprae [38] induce IL-10 nificant differences in IL-12 p40 levels were found between / 9d41$$mr11
12-24-97 00:44:39 jinfal UC: J Infect production in PBMC cultures, with monocytes as the prenated by IL-4 and IL-10) contributes to disease progression in patients with HIV [6, 7, 40] ; however, other data have not dominant source of IL-10.
In contrast to the cultures stimulated by mycobacterial prepasupported this hypothesis [5, 10, 41] . Our findings are clearly relevant to this discussion. We report here that the cellular rations, PHA-stimulated PBMC cultures from HIV-infected patients, compared with controls, produced lower IL-10 levels, sources of IL-10 production depend on the nature of the stimulus since IL-10 is only partially (mitogen stimulation) or only with the lowest levels being in patients with the most advanced disease. Several cell types produced IL-10 in response to PHA, to a small extent (stimulation by MAC preparations) derived from CD4 lymphocytes. Production of IL-10 in mixed cell particularly CD4 lymphocytes and monocytes. Thus, the reduced number of CD4 lymphocytes in the patient PBMC culpopulations, such as PBMC, should be interpreted carefully and does not necessarily depend on Th2 lymphocytes, as has tures might be of importance for their lower IL-10 production. There are discrepant reports concerning IL-10 production in also been suggested by others [5] . We suggest that increased IL-10 release from monocytes and macrophages is of para-PBMC cultures after PHA stimulation during HIV infection [6, 7, 9, 10, 24, 39] , and conflicting results may partly be due mount importance for the elevated IL-10 production in HIV infection. to different proportions of CD4 lymphocytes in PBMC cultures in different studies.
IL-10 normally has a down-regulating effect on production of several other cytokines, such as TNF-a and IL-12 [3, 42, Several reports have suggested that a shift in cytokine pattern from Th1 (dominated by interferon-g and IL-2) to Th2 (domi-43] . This led us to examine the interplay between IL-10 and
